Cadila Pharma readies cardiovascular drug
The Ahmedabad-based pharma major Cadila Pharmaceuticals Ltd (CPL) is all set for launch of its new cardiovascular drug Fovas after acquiring approval from the Drug Controller General of India (DCGI)
The Ahmedabad-based pharma major Cadila Pharmaceuticals Ltd (CPL) is all set for launch of its new cardiovascular drug Fovas after acquiring approval from the Drug Controller General of India (DCGI)